HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,543,471 | +178.2% | 40,405 | +162.6% | 0.19% | +167.1% |
Q2 2023 | $554,901 | -79.0% | 15,384 | -77.8% | 0.07% | -76.7% |
Q1 2023 | $2,646,300 | +24.1% | 69,293 | +84.9% | 0.30% | +23.5% |
Q4 2022 | $2,132,953 | +341.6% | 37,486 | +209.5% | 0.24% | +367.3% |
Q1 2022 | $483,000 | -86.9% | 12,113 | -86.6% | 0.05% | -81.6% |
Q3 2021 | $3,690,000 | +344.6% | 90,705 | +355.6% | 0.28% | +293.1% |
Q1 2021 | $830,000 | -22.0% | 19,907 | -50.8% | 0.07% | +5.9% |
Q3 2020 | $1,064,000 | +20.0% | 40,490 | +22.4% | 0.07% | -16.0% |
Q2 2020 | $887,000 | +124.0% | 33,078 | +48.1% | 0.08% | +237.5% |
Q4 2019 | $396,000 | – | 22,335 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |